Using AI to prevent harm caused by immunotherapy ohiostandard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ohiostandard.com Daily Mail and Mail on Sunday newspapers.
AI Helps to Study Which Cancer Patients Might be Harmed by Immunotherapy
Written by AZoRoboticsFeb 5 2021
At Case Western Reserve University, scientists have used artificial intelligence (AI) to analyze simple tissue scans and discovered biomarkers that could pinpoint to doctors those lung cancer patients who might actually suffer worse from immunotherapy.
Image credit: Design Cells/shutterstock.com
To date, oncologists and scientists had classified these lung cancer patients into two wider categories those who would benefit from immunotherapy, and those who would probably not.
However, according to Pranjal Vaidya, a PhD student in biomedical engineering and researcher at the university’s Center for Computational Imaging and Personalized Diagnostics (CCIPD), a third category of patients has started to emerge hyper-progressors who would actually get worse by immunotherapy, such as a very short lifespan following treatment.
AI technology can help prevent adverse effect of immunotherapy in certain lung cancer patients
Researchers at Case Western Reserve University, using artificial intelligence (AI) to analyze simple tissue scans, say they have discovered biomarkers that could tell doctors which lung cancer patients might actually get worse from immunotherapy.
Until recently, researchers and oncologists had placed these lung cancer patients into two broad categories: those who would benefit from immunotherapy, and those who likely would not.
But a third category patients called hyper-progressors who would actually be harmed by immunotherapy, including a shortened lifespan after treatment has begun to emerge, said Pranjal Vaidya, a PhD student in biomedical engineering and researcher at the university s Center for Computational Imaging and Personalized Diagnostics (CCIPD).
E-Mail
CLEVELAND Researchers at Case Western Reserve University, using artificial intelligence (AI) to analyze simple tissue scans, say they have discovered biomarkers that could tell doctors which lung cancer patients might actually get worse from immunotherapy.
Until recently, researchers and oncologists had placed these lung cancer patients into two broad categories: those who would benefit from immunotherapy, and those who likely would not.
But a third category patients called hyper-progressors who would actually be harmed by immunotherapy, including a shortened lifespan after treatment has begun to emerge, said Pranjal Vaidya, a PhD student in biomedical engineering and researcher at the university s Center for Computational Imaging and Personalized Diagnostics (CCIPD).
PhD Student Researcher in Computational Imaging and Machine Learning
Center for Computational Imaging and Personalized Diagnostics at Case Western Reserve University, Cleveland, OH, United States
The job you tried to view is no longer active on the site.
LATEST JOB POSTINGS